arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Embecta Corp.

EMBC
$4.41 ▲ +0.89 (+25.14%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
7 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

Embecta Corp. shows strong fundamentals with top-quartile Debt to Equity and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $257.1M
Dividend Yield 13.61%
Revenue Growth -3.8%
Op. Margin 22.4%
ROIC 22.7%
FCF / Share $3.13
Trailing P/E 2.7x
Price / Book
FCF Yield 70.9%
Debt / Equity -2.15
info Valuation on last close. End-of-day price, Aug 7, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.08B
↓ -3.8%
Net Income Profit after all expenses
$95.40M
↑ +21.8%
Operating Margin Operating profit as % of sales
22.4%
↑ +50.9% 78th
FCF / Share Free cash flow per share
$3.13
↑ +806.7%
Long-Term Debt Long-term obligations
$1.40B
↓ -11.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
72
Returns
31
Financial Health
81
Cash Quality
85

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
+0.0% YoY
+58.7% 4-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 24 quarters